This is a Validated Antibody Database (VAD) review about human IKZF3, based on 6 published articles (read how Labome selects the articles), using IKZF3 antibody in all methods. It is aimed to help Labome visitors find the most suited IKZF3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IKZF3 synonym: AIO; AIOLOS; ZNFN1A3

Abcam
domestic rabbit monoclonal (EPR9342(B))
  • western blot; human; loading ...; fig 4c
Abcam IKZF3 antibody (Abcam, ab139408) was used in western blot on human samples (fig 4c). Leukemia (2019) ncbi
domestic rabbit monoclonal (EPR9342(B))
  • western blot; human; 1:10,000; loading ...; fig 3
Abcam IKZF3 antibody (Abcam, ab139408) was used in western blot on human samples at 1:10,000 (fig 3). Oncol Lett (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D1C1E)
  • western blot; human; loading ...; fig 1g
Cell Signaling Technology IKZF3 antibody (Cell Signaling Technology, 15103) was used in western blot on human samples (fig 1g). Sci Adv (2021) ncbi
domestic rabbit monoclonal (D1C1E)
  • ChIP-Seq; human; 1-2 ug / 500 ul chr; loading ...; fig 4c
Cell Signaling Technology IKZF3 antibody (Cell Signaling, 15103) was used in ChIP-Seq on human samples at 1-2 ug / 500 ul chr (fig 4c). Cell Rep (2019) ncbi
domestic rabbit monoclonal (D1C1E)
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology IKZF3 antibody (Cell Signaling, 15103) was used in western blot on human samples (fig 1e). Leukemia (2019) ncbi
domestic rabbit monoclonal (D1C1E)
  • western blot; mouse; fig s4
In order to use knockout mice to determine the role of cereblon in T cells, Cell Signaling Technology IKZF3 antibody (Cell Signaling, D1C1E) was used in western blot on mouse samples (fig s4). Proc Natl Acad Sci U S A (2016) ncbi
Articles Reviewed
  1. Liu J, Hideshima T, Xing L, Wang S, Zhou W, Samur M, et al. ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment. Sci Adv. 2021;7: pubmed publisher
  2. Senigl F, Maman Y, Dinesh R, Alinikula J, Seth R, Pecnova L, et al. Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation. Cell Rep. 2019;29:3902-3915.e8 pubmed publisher
  3. Zhou N, Gutierrez Uzquiza A, Zheng X, Chang R, Vogl D, Garfall A, et al. RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation. Leukemia. 2019;: pubmed publisher
  4. Liu J, Song T, Zhou W, Xing L, Wang S, Ho M, et al. A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity. Leukemia. 2019;33:171-180 pubmed publisher
  5. Jian Y, Gao W, Geng C, Zhou H, Leng Y, Li Y, et al. Arsenic trioxide potentiates sensitivity of multiple myeloma cells to lenalidomide by upregulating cereblon expression levels. Oncol Lett. 2017;14:3243-3248 pubmed publisher
  6. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher